Insufficient scRNA-seq data for expression of MYMK at single-cell level.
Insufficient scRNA-seq data for expression of MYMK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 80% | 9.00 | 71 / 89 | 5% | 0.10 | 44 / 901 |
lung | 65% | 5.04 | 376 / 578 | 2% | 0.04 | 22 / 1155 |
muscle | 62% | 16.60 | 499 / 803 | 0% | 0 | 0 / 0 |
brain | 51% | 4.48 | 1349 / 2642 | 2% | 0.03 | 12 / 705 |
adrenal gland | 48% | 1.91 | 125 / 258 | 0% | 0.04 | 1 / 230 |
spleen | 44% | 2.07 | 107 / 241 | 0% | 0 | 0 / 0 |
thymus | 33% | 2.59 | 215 / 653 | 2% | 0.06 | 12 / 605 |
liver | 29% | 1.12 | 66 / 226 | 5% | 0.37 | 21 / 406 |
pancreas | 31% | 0.91 | 103 / 328 | 3% | 0.10 | 5 / 178 |
heart | 30% | 1.34 | 255 / 861 | 0% | 0 | 0 / 0 |
prostate | 27% | 2.06 | 67 / 245 | 2% | 0.05 | 10 / 502 |
ovary | 18% | 0.68 | 33 / 180 | 10% | 0.23 | 45 / 430 |
bladder | 24% | 0.95 | 5 / 21 | 0% | 0.04 | 2 / 504 |
uterus | 14% | 0.43 | 23 / 170 | 6% | 6.22 | 27 / 459 |
skin | 18% | 0.63 | 333 / 1809 | 0% | 0.01 | 2 / 472 |
breast | 18% | 1.13 | 83 / 459 | 1% | 0.02 | 8 / 1118 |
esophagus | 15% | 0.64 | 222 / 1445 | 2% | 0.13 | 3 / 183 |
peripheral blood | 14% | 0.87 | 131 / 929 | 0% | 0 | 0 / 0 |
adipose | 13% | 0.54 | 154 / 1204 | 0% | 0 | 0 / 0 |
stomach | 11% | 0.28 | 39 / 359 | 1% | 0.02 | 4 / 286 |
blood vessel | 11% | 0.70 | 146 / 1335 | 0% | 0 | 0 / 0 |
intestine | 7% | 0.17 | 63 / 966 | 2% | 0.04 | 10 / 527 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.16 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904206 | Biological process | positive regulation of skeletal muscle hypertrophy |
GO_0007520 | Biological process | myoblast fusion |
GO_0014905 | Biological process | myoblast fusion involved in skeletal muscle regeneration |
GO_0007517 | Biological process | muscle organ development |
GO_0045026 | Biological process | plasma membrane fusion |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005886 | Cellular component | plasma membrane |
Gene name | MYMK |
Protein name | Protein myomaker (Myoblast fusion maker) (Transmembrane protein 226) (Transmembrane protein 8C) |
Synonyms | TMEM8C TMEM226 |
Description | FUNCTION: Myoblast-specific protein that mediates myoblast fusion, an essential step for the formation of multi-nucleated muscle fibers . Actively participates in the membrane fusion reaction by mediating the mixing of cell membrane lipids (hemifusion) upstream of MYMX. Acts independently of MYMX (By similarity). Involved in skeletal muscle regeneration in response to injury by mediating the fusion of satellite cells, a population of muscle stem cells, with injured myofibers (By similarity). Also involved in skeletal muscle hypertrophy, probably by mediating the fusion of satellite cells with myofibers (By similarity). . |
Accessions | ENST00000339996.4 A6NI61 |